Epithelial‐Mesenchymal Transition, Immune Response, and Extracellular Matrix Remodelling in Oral Cancer
Journal of Oral Pathology & Medicine · 2026
DOI: 10.1111/jop.70126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2026. Verfasst von Nicole Lonni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Health Sciences Center, Federal University of Santa Catarina, SC, Brazil. Hauptthemen laut MEDLINE: Mouth Neoplasms, Epithelial-Mesenchymal Transition, Carcinoma, Squamous Cell, Extracellular Matrix. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Aim
This retrospective study investigates the interplay between epithelial‐mesenchymal transition (EMT) and immune response within the tumor microenvironment (TME) of oral squamous cell carcinoma (OSCC). Methodology Immunohistochemistry was conducted on OSCC specimens to evaluate the expression of podoplanin (PDP), E‐cadherin (CDH1), vimentin (VIM), fibronectin (FN), tenascin‐C (TNC), and vascular endothelial growth factor (VEGF). Cancer‐associated fibroblasts (CAFs) were identified by alpha‐smooth muscle actin (α‐SMA), and immune cells were quantified using CD66b for neutrophils and CD8 for T lymphocytes.
Results
Higher α‐SMA and moderate‐to‐strong VEGF expression were associated with reduced CDH1 and increased VIM and PDP expression ( p < 0.05), indicating an EMT‐like phenotype. Cases with elevated PDP—also linked to high α‐SMA—showed increased CD66b + cell density ( p = 0.072). VEGF expression additionally correlated with greater tumor thickness and depth of invasion ( p = 0.059). Strong TNC expression was associated with reduced CD8 + T‐cell infiltration in the tumor centre and increased CD66b + neutrophils ( p < 0.046). Strong FN expression was linked to a higher neutrophil‐to‐lymphocyte ratio ( p = 0.031). Elevated CD66b + cell counts and a higher neutrophil‐to‐lymphocyte ratio were both significantly associated with poorer overall survival ( p < 0.015).
Conclusion
These exploratory findings suggest that CAFs serve not only as a marker of stromal activation but may also contribute to immunomodulation and invasive tumor phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Sciences Center, Federal University of Santa Catarina, SC, Brazil.
- College of Dentistry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
- Department of Pathology, Health Sciences Center, Federal University of Santa Catarina, SC, Brazil.
ORCID-Profile: Nicole Lonni, Camilla Kammer Pereira, Amanda Maciel Costa, Aline Hsiao Bona, Andressa Fernanda Paza Miguel, Elis Ângela Batistella, Daniella Serafin Couto Vieira, Elena Riet Correa Rivero
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Lonni, N., Pereira, C. K., Costa, A. M., Bona, A. H., Miguel, A. F. P., Batistella, E. Â., Vieira, D. S. C., & Rivero, E. R. C. (2026). Epithelial‐Mesenchymal Transition, Immune Response, and Extracellular Matrix Remodelling in Oral Cancer. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.70126
Vancouver
Lonni N, Pereira CK, Costa AM, Bona AH, Miguel AFP, Batistella EÂ, et al. Epithelial‐Mesenchymal Transition, Immune Response, and Extracellular Matrix Remodelling in Oral Cancer. Journal of Oral Pathology & Medicine. 2026. doi:10.1111/jop.70126
BibTeX
@article{Lonni2026,
author = {Lonni, Nicole and Pereira, Camilla Kammer and Costa, Amanda Maciel and Bona, Aline Hsiao and Miguel, Andressa Fernanda Paza and Batistella, Elis Ângela and Vieira, Daniella Serafin Couto and Rivero, Elena Riet Correa},
title = {Epithelial‐Mesenchymal Transition, Immune Response, and Extracellular Matrix Remodelling in Oral Cancer},
journal = {Journal of Oral Pathology & Medicine},
year = {2026},
doi = {10.1111/jop.70126}
}
EUVIMED